Author Photo
Written by:

Taxotere® Linked to Permanent Hair Loss

| Read Time: 2 minutes

Taxotere® Alopecia

American women are more likely to be diagnosed with breast cancer than any other form of cancer. And when women undergo chemotherapy while fighting the disease, they are often given Taxotere®, an injectable drug. While most patients are told to expect temporary hair loss during their treatment, some cancer survivors who were treated with Taxotere experience a side effect they weren’t warned about—permanent significant hair loss (alopecia) of the head, face (eyelashes and eyebrows) and body.

Permanent hair loss is more than cosmetic for cancer survivors; it is a constant reminder of their struggle and loss.  Hair loss is ranked amongst the most troubling side effects of cancer, as it can be distressing and can seriously affect a women’s self-esteem.

A study published in Annals of Oncology examined 20 female breast cancer patients and linked Taxotere to severe and permanent female hair loss. Other known causes of permanent female hair loss were excluded in the study and multiple treatments were all ineffective.

At Cory Watson Attorneys, we’ve helped drug injury victims through some of the most difficult times of their lives for more than 30 years. Our lawyers understand the incredible battle that cancer survivors must endure to get to remission, and we don’t think it’s right that you should have to endure an unexpected side effect that can affect your body image and self-esteem for life.

We’ve helped clients across the nation recover more than 3 Billion for their injuries, and our drug injury attorneys can help you, too. Call our 24/7 team to get started now—call (877) 686-8992 or complete our free initial consultation form.

  • Subscribe to Our Blog